278 related articles for article (PubMed ID: 11122261)
1. Opsonization of apoptotic neutrophils by anti-neutrophil cytoplasmic antibodies (ANCA) leads to enhanced uptake by macrophages and increased release of tumour necrosis factor-alpha (TNF-alpha).
Moosig F; Csernok E; Kumanovics G; Gross WL
Clin Exp Immunol; 2000 Dec; 122(3):499-503. PubMed ID: 11122261
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
Harper L; Cockwell P; Adu D; Savage CO
Kidney Int; 2001 May; 59(5):1729-38. PubMed ID: 11318943
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil activation by anti-proteinase 3 antibodies in Wegener's granulomatosis: role of exogenous arachidonic acid and leukotriene B4 generation.
Grimminger F; Hattar K; Papavassilis C; Temmesfeld B; Csernok E; Gross WL; Seeger W; Sibelius U
J Exp Med; 1996 Oct; 184(4):1567-72. PubMed ID: 8879231
[TBL] [Abstract][Full Text] [Related]
4. Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils.
Van Rossum AP; van der Geld YM; Limburg PC; Kallenberg CG
Kidney Int; 2005 Aug; 68(2):537-41. PubMed ID: 16014030
[TBL] [Abstract][Full Text] [Related]
5. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to neutrophil cytoplasmic antigens (ANCA) do not bind to polymorphonuclear neutrophils in blood.
Abdel-Salam B; Iking-Konert C; Schneider M; Andrassy K; Hänsch GM
Kidney Int; 2004 Sep; 66(3):1009-17. PubMed ID: 15327394
[TBL] [Abstract][Full Text] [Related]
7. Anti-myeloperoxidase antibodies enhance phagocytosis, IL-8 production, and glucose uptake of polymorphonuclear neutrophils rather than anti-proteinase 3 antibodies leading to activation-induced cell death of the neutrophils.
Hsieh SC; Yu HS; Cheng SH; Li KJ; Lu MC; Wu CH; Tsai CY; Yu CL
Clin Rheumatol; 2007 Feb; 26(2):216-24. PubMed ID: 16575489
[TBL] [Abstract][Full Text] [Related]
8. Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo.
Csernok E; Ernst M; Schmitt W; Bainton DF; Gross WL
Clin Exp Immunol; 1994 Feb; 95(2):244-50. PubMed ID: 8306499
[TBL] [Abstract][Full Text] [Related]
9. Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA/PR3 immunecomplexes.
Sun J; Fass DN; Hudson JA; Viss MA; Wieslander J; Homburger HA; Specks U
J Immunol Methods; 1998 Feb; 211(1-2):111-23. PubMed ID: 9617836
[TBL] [Abstract][Full Text] [Related]
10. Proteinase 3, the Wegener autoantigen, is externalized during neutrophil apoptosis: evidence for a functional association with phospholipid scramblase 1 and interference with macrophage phagocytosis.
Kantari C; Pederzoli-Ribeil M; Amir-Moazami O; Gausson-Dorey V; Moura IC; Lecomte MC; Benhamou M; Witko-Sarsat V
Blood; 2007 Dec; 110(12):4086-95. PubMed ID: 17712045
[TBL] [Abstract][Full Text] [Related]
11. Subthreshold concentrations of anti-proteinase 3 antibodies (c-ANCA) specifically prime human neutrophils for fMLP-induced leukotriene synthesis and chemotaxis.
Hattar K; Sibelius U; Bickenbach A; Csernok E; Seeger W; Grimminger F
J Leukoc Biol; 2001 Jan; 69(1):89-97. PubMed ID: 11200073
[TBL] [Abstract][Full Text] [Related]
12. Human mast cells expressing recombinant proteinase 3 (PR3) as substrate for clinical testing for anti-neutrophil cytoplasmic antibodies (ANCA).
Specks U; Wiegert EM; Homburger HA
Clin Exp Immunol; 1997 Aug; 109(2):286-95. PubMed ID: 9276524
[TBL] [Abstract][Full Text] [Related]
13. Recombinant proteinase 3 produced in different expression systems: recognition by anti-PR3 antibodies.
van der Geld YM; Oost-Kort W; Limburg PC; Specks U; Kallenberg CG
J Immunol Methods; 2000 Oct; 244(1-2):117-31. PubMed ID: 11033024
[TBL] [Abstract][Full Text] [Related]
14. The influence of different cultivating conditions on polymorphonuclear leukocyte apoptotic process in vitro, II: ultrastructural characteristics of PMN populations incubated with proteinase 3 anti-neutrophil autoantibodies.
Guejes L; Zurgil N; Stambler I; Deutsch M; Gilburd B; Shoenfeld Y
Ultrastruct Pathol; 2005; 29(1):37-51. PubMed ID: 15931779
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies to early endosome antigen (EEA1) produce a staining pattern resembling cytoplasmic anti-neutrophil cytoplasmic antibodies (C-ANCA).
Selak S; Woodman RC; Fritzler MJ
Clin Exp Immunol; 2000 Dec; 122(3):493-8. PubMed ID: 11122260
[TBL] [Abstract][Full Text] [Related]
16. Anti-proteinase 3 antibodies (c-ANCA) prime CD14-dependent leukocyte activation.
Hattar K; van Bürck S; Bickenbach A; Grandel U; Maus U; Lohmeyer J; Csernok E; Hartung T; Seeger W; Grimminger F; Sibelius U
J Leukoc Biol; 2005 Oct; 78(4):992-1000. PubMed ID: 16006536
[TBL] [Abstract][Full Text] [Related]
17. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
Csernok E; Ahlquist D; Ullrich S; Gross WL
Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
[TBL] [Abstract][Full Text] [Related]
18. Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis.
Muller Kobold AC; Kallenberg CG; Tervaert JW
Br J Rheumatol; 1998 Aug; 37(8):901-7. PubMed ID: 9734683
[TBL] [Abstract][Full Text] [Related]
19. Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity.
van de Wiel BA; Dolman KM; van der Meer-Gerritsen CH; Hack CE; von dem Borne AE; Goldschmeding R
Clin Exp Immunol; 1992 Dec; 90(3):409-14. PubMed ID: 1458677
[TBL] [Abstract][Full Text] [Related]
20. Wegener's granulomatosis: anti-proteinase 3 antibodies are potent inductors of human endothelial cell signaling and leakage response.
Sibelius U; Hattar K; Schenkel A; Noll T; Csernok E; Gross WL; Mayet WJ; Piper HM; Seeger W; Grimminger F
J Exp Med; 1998 Feb; 187(4):497-503. PubMed ID: 9463400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]